A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

NCT00796783 · clinicaltrials.gov ↗

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Cushing's Syndrome

Interventions

DRUG: Cushing's syndrome confirmation

Sponsor

Corcept Therapeutics